title: Incidence and patterns of ALK FISH abnormalities seen in a large unselected series of lung carcinomas.
abstract: BACKGROUND
  Anaplastic lymphoma receptor tyrosine kinase (ALK) gene rearrangements have been reported in 2-13% of patients with non-small cell lung cancer (NSCLC). Patients with ALK rearrangements do not respond to EGFR-specific tyrosine kinase inhibitors (TKIs); however, they do benefit from small molecule inhibitors targeting ALK.
  
  
  RESULTS
  In this study, fluorescence in situ hybridization (FISH) using a break-apart probe for the ALK gene was performed on formalin fixed paraffin-embedded tissue to determine the incidence of ALK rearrangements and hybridization patterns in a large unselected cohort of 1387 patients with a referred diagnosis of non-small cell lung cancer (1011 of these patients had a histologic diagnosis of adenocarcinoma). The abnormal FISH signal patterns varied from a single split signal to complex patterns. Among 49 abnormal samples (49/1387, 3.5%), 32 had 1 to 3 split signals. Fifteen samples had deletions of the green 5' end of the ALK signal, and 1 of these 15 samples showed amplification of the orange 3' end of the ALK signal. Two patients showed a deletion of the 3'ALK signal. Thirty eight of these 49 samples (38/1011, 3.7%) were among the 1011 patients with confirmed adenocarcinoma. Five of 8 patients with ALK rearrangements detected by FISH were confirmed to have EML4-ALK fusions by multiplex RT-PCR. Among the 45 ALK-rearranged samples tested, only 1 EGFR mutation (T790M) was detected. Two KRAS mutations were detected among 24 ALK-rearranged samples tested.
  
  
  CONCLUSIONS
  In a large unselected series, the frequency of ALK gene rearrangement detected by FISH was approximately 3.5% of lung carcinoma, and 3.7% of patients with lung adenocarcinoma, with variant signal patterns frequently detected. Rare cases with coexisting KRAS and EGFR mutations were seen.
authors.affiliation: Department of Cytogenetics, Quest Diagnostics Nichols Institute, 14225 Newbrook Drive, Chantilly, VA, 20151, USA. Zunyan.X.Dai@questdiagnostics.com.
authors.forename: Zunyan
authors.initials: Z
authors.lastname: Dai
authors.forename: Joann C
authors.initials: JC
authors.lastname: Kelly
authors.forename: Aurelia
authors.initials: A
authors.lastname: Meloni-Ehrig
authors.forename: Marilyn L
authors.initials: ML
authors.lastname: Slovak
authors.forename: Debra
authors.initials: D
authors.lastname: Boles
authors.forename: Nicole C
authors.initials: NC
authors.lastname: Christacos
authors.forename: Christine R
authors.initials: CR
authors.lastname: Bryke
authors.forename: Steven A
authors.initials: SA
authors.lastname: Schonberg
authors.forename: Jennifer
authors.initials: J
authors.lastname: Otani-Rosa
authors.forename: Qiulu
authors.initials: Q
authors.lastname: Pan
authors.forename: Albert K
authors.initials: AK
authors.lastname: Ho
authors.forename: Heather R
authors.initials: HR
authors.lastname: Sanders
authors.forename: Zhong J
authors.initials: ZJ
authors.lastname: Zhang
authors.forename: Dan
authors.initials: D
authors.lastname: Jones
authors.forename: Philip N
authors.initials: PN
authors.lastname: Mowrey